Identification of predictive biomarkers of overall survival (OS) in patients (pts) with advanced renal cell carcinoma (RCC) treated with interferon alpha (I) with or without bevacizumab (B): Results from CALGB 90206 (Alliance).
暂无分享,去创建一个
Ivo D. Shterev | P. Febbo | E. Small | B. Rini | H. Hurwitz | J. Dutcher | D. George | S. Halabi | A. Nixon | M. Starr | J. Hopkins | J. C. Brady